StockData
Protalix BioTherapeutics, Inc. logo

Protalix BioTherapeutics, Inc. (PLX) stock

PLXNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 16/3047% below fair value
$2.88−0.15 (-4.95%)

Close on Nov 17, 2026Market cap $232.05MP/E 12.5Yield –

Protalix BioTherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Protalix BioTherapeutics's market cap was $255.04M on Nov 11, 2026, against $152.65M a year earlier. Over the last 5 years it ranged from $34.15M to $255.04M, with a median of $112.96M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$255.04M+65.2%
2025Dec 31, 2025$154.36M+4.5%
2024Dec 31, 2024$147.64M+20.4%
2023Dec 29, 2023$122.64M+90.5%
2022Dec 30, 2022$64.37M+88.5%
2021Dec 31, 2021$34.15M-39.2%
2020Dec 31, 2020$56.17M+15.4%
2019Dec 31, 2019$48.66M-99.6%
2018Dec 31, 2018$11.29B+12192.4%
2017Dec 29, 2017$91.88M+105.1%
2016Dec 30, 2016$44.80M-53.0%
2015Dec 31, 2015$95.33M-44.1%
2014Dec 31, 2014$170.67M-52.4%
2013Dec 31, 2013$358.68M-23.2%
2012Dec 31, 2012$467.31M-10.7%
2011Jul 29, 2011$523.24M–

More Protalix BioTherapeutics figures

See a number that looks wrong?